Exhibit 99.2
APPENDIX 4E - PRELIMINARY FINAL REPORT |
1. Company details
Name of entity: | Kazia Therapeutics Limited | |
ABN: | 37 063 259 754 | |
Reporting period: | For the year ended 30 June 2023 | |
Previous period: | For the year ended 30 June 2022 |
2. Results for announcement to the market
2022 | ||||||||||||||||
2023 | restated | Change | Change | |||||||||||||
$ | $ | $ | % | |||||||||||||
Loss from ordinary activities after tax attributable to the owners of Kazia Therapeutics Limited | (20,465,180 | ) | (25,014,055 | ) | 4,548,875 | (18%) | ||||||||||
Loss for the year attributable to the owners of Kazia Therapeutics Limited | (20,465,180 | ) | (25,014,055 | ) | 4,548,875 | (18%) |
3. Net tangible assets
Reporting | Previous | |||||||
period | period | |||||||
Cents | Cents | |||||||
Net tangible assets per ordinary security | (2.29 | ) | (0.62) |
4. Control gained over entities
Not applicable.
5. Loss of control over entities
Kazia Therapeutics (Hong Kong) Limited - Deregistered and dissolved on 10 March 2023.
6. Dividends
Current period
There were no dividends paid, recommended or declared during the current financial period.
Previous period
There were no dividends paid, recommended or declared during the previous financial period.
7. Dividend reinvestment plans
Not applicable.
8. Details of associates and joint venture entities
Not applicable.
Kazia Theraputics Limited Appendix 4E 2023 | i |
APPENDIX 4E - PRELIMINARY FINAL REPORT |
9. Foreign entities
Details of origin of accounting standards used in compiling the report:
Not applicable.
10. Audit qualification or review
Details of audit/review dispute or qualification (if any):
The financial statements have been audited and an unqualified opinion with an emphasis of matter around going concern has been issued.
11. Attachments
Details of attachments (if any):
The Directors’ report and financial statements of Kazia Therapeutics Limited for the year ended 30 June 2023 is attached.
12. Signed
Dr John Friend |
Interim Chairman, Managing |
Director, Chief Executive Officer |
Date: 31 August 2023 |
Kazia Theraputics Limited Appendix 4E 2023 | ii |